Suchergebnisse - "Subbiah, Vivek"

PubPharm (28)

1

TRKing sarcomas for precision medicine : Seek, and ye shall find!

enthalten in: Cancer | 2023

von Moyers, J. | Subbiah, V.

CommentOn: Cancer. 2023 Dec 1;129(23):3772-3782. - PMID 37769113

2

RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and Beyond

enthalten in: Cancer research | 2023

von Wu, J. | Subbiah, V.

CommentOn: Cancer Res. 2023 Oct 2;83(19):3237-3251. - PMID 37071495

3

For what it's worth : the complex area of medicine value assessment

enthalten in: Journal of comparative effectiveness research | 2023

von Ramagopalan, S. | Treharne, C. | Pearson-Stuttard, J. | +1

CommentOn: JAMA. 2023 Apr 18;329(15):1283-1289. - PMID 37071095

4

Direct-to-Patient Clinical Trials : One Small Step or a Giant Leap?

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Desai, A. | Subbiah, V.

CommentIn: Clin Cancer Res. 2023 Jul 5;29(13):2445-2455. - PMID 36862133

5

Exportin(g) precision oncology beyond genomics with XPO1 inhibition

enthalten in: Med (New York, N.Y.) | 2022

von Gouda, M. | Subbiah, V.

CommentOn: Med (N Y). 2022 Nov 11;3(11):774-791.e7. - PMID 36195086

6

Targeting Ferroptosis Vulnerability in Synovial Sarcoma : Is It All About ME1?

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Subbiah, V. | Gan, B.

CommentOn: Clin Cancer Res. 2022 Aug 15;28(16):3573-3589. - PMID 35421237

7

Think Globally, Act Locally : Globalizing Precision Oncology

enthalten in: Cancer discovery | 2022

von Moyers, J. | Subbiah, V.

CommentOn: Cancer Discov. 2022 Apr 1;12(4):938-948. - PMID 34862196

8

ROAR trial : which treatment is effective after progression? - Authors' reply

enthalten in: The Lancet. Oncology | 2022

von Wen, P. | Burgess, P. | Ilankumaran, P. | +1

CommentOn: Lancet Oncol. 2022 Jan;23(1):53-64. - PMID 34838156

9

Assessment of tumour-agnostic therapies in basket trials

enthalten in: The Lancet. Oncology | 2022

von Popat, S. | Ramagopalan, S. | Ray, J. | +2

CommentOn: Lancet Oncol. 2021 Oct;22(10):e430-e434. - PMID 34592192

10

Author response to Cunha et al

enthalten in: Journal for immunotherapy of cancer | 2021

von Colen, R. | Rolfo, C. | Ak, M. | +15

CommentOn: J Immunother Cancer. 2021 Jul;9(7):. - PMID 34315822